Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP549045.RAcT0prRrNvsN8ZKtwCpxhoVbR3A4O4BPRTiQh72Ho09E130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP549045.RAcT0prRrNvsN8ZKtwCpxhoVbR3A4O4BPRTiQh72Ho09E130_assertion type Assertion NP549045.RAcT0prRrNvsN8ZKtwCpxhoVbR3A4O4BPRTiQh72Ho09E130_head.
- NP549045.RAcT0prRrNvsN8ZKtwCpxhoVbR3A4O4BPRTiQh72Ho09E130_assertion description "[Upregulation of the antiapoptotic MCL-1 [P = 0.001, hazard ratio (HR) 1.5] and BNIP3 (P = 0.024; HR, 1.4) was associated with worse prognosis considering metastasis-free interval, whereas clusterin (P = 0.008; HR, 0.88) and the proapoptotic BCL2L13 (P = 0.019; HR, 0.45) were associated with better prognosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP549045.RAcT0prRrNvsN8ZKtwCpxhoVbR3A4O4BPRTiQh72Ho09E130_provenance.
- NP549045.RAcT0prRrNvsN8ZKtwCpxhoVbR3A4O4BPRTiQh72Ho09E130_assertion evidence source_evidence_literature NP549045.RAcT0prRrNvsN8ZKtwCpxhoVbR3A4O4BPRTiQh72Ho09E130_provenance.
- NP549045.RAcT0prRrNvsN8ZKtwCpxhoVbR3A4O4BPRTiQh72Ho09E130_assertion SIO_000772 20068093 NP549045.RAcT0prRrNvsN8ZKtwCpxhoVbR3A4O4BPRTiQh72Ho09E130_provenance.
- NP549045.RAcT0prRrNvsN8ZKtwCpxhoVbR3A4O4BPRTiQh72Ho09E130_assertion wasDerivedFrom befree-20150227 NP549045.RAcT0prRrNvsN8ZKtwCpxhoVbR3A4O4BPRTiQh72Ho09E130_provenance.
- NP549045.RAcT0prRrNvsN8ZKtwCpxhoVbR3A4O4BPRTiQh72Ho09E130_assertion wasGeneratedBy ECO_0000203 NP549045.RAcT0prRrNvsN8ZKtwCpxhoVbR3A4O4BPRTiQh72Ho09E130_provenance.